Intestinal production of triglyceride-rich lipoproteins has also been shown to be affected by glucagon-like peptide 1 (GLP-1) (Mulvihill 2018), an incretin produced by the gut that has been reported to play a key role in inducing satiety, reducing food intake and controlling obesity. This evidence concerns the gene GCG and obesity disorder.